New FDA Approved Inhalers for Asthma and COPD Patients in the Market
Breo Ellipta by GSK
- Its a dry powder inhaler only approved for COPD patients and not for Asthma patients
- Main draw back is if you open and then close the inhaler cover without inhaling the medicine, one dose is lost & the inhaler comes only with 30 doses
- You have to be careful while using Breo Ellipta, do not open cover until you are ready to inhale
Arnuity Ellipta by GSK